WASHINGTON — Peter Marks, the former top vaccine regulator at the Food and Drug Administration, has joined Eli Lilly to oversee molecule discovery and infectious diseases — a move likely to rile up critics of the revolving door between FDA and industry.

Marks confirmed his new role to STAT. His first day was yesterday.

“I am excited about the potential to help benefit people by advancing the development of vaccines for public health,” Marks told STAT.

“Lilly continually evaluates breakthrough science which could benefit patients,” said Lilly spokesperson Stefanie Prodouz. “Peter’s expertise strengthens our abilities across multiple areas, both in our existing portfolio and in our work in emerging areas.”

BioCentury reported the news earlier on social media.

Marks lost his job at the

See Full Page